Brevan Howard Capital Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$175K	Sell	34,743 -69,579	-67%	-$351K	﹤0.01%	1645
2025 Q1	$676K	Buy	104,322 +83,689	+406%	+$542K	0.01%	584
2024 Q4	$151K	Buy	+20,633	New	+$151K	﹤0.01%	909
2024 Q3	–	Sell	-46,087	Closed	-$410K	–	1412
2024 Q2	$410K	Buy	+46,087	New	+$410K	﹤0.01%	626